Trademark: 90727451
Word
SEACROSS
Status
Registered
Status Code
700
Status Date
Tuesday, February 14, 2023
Serial Number
90727451
Registration Number
6976777
Registration Date
Tuesday, February 14, 2023
Mark Type
5000
Filing Date
Friday, May 21, 2021
Published for Opposition
Tuesday, November 29, 2022

Trademark Owner History

Classifications
5 Chemical contraceptives; drugs for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; bacterial preparations for medical and veterinary use; bouillons for bacteriological cultures; biochemical medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; prepared Chinese medicine, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; antibiotics; diagnostic preparations for medical purposes; medicines for human purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicines for dental purposes; chemical preparations for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemical preparations for pharmaceutical purposes, namely, contrast agents; chemical preparations for pharmaceutical purposes, namely, antidote; syrups for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; capsules for medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemico-pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; collyrium; biological preparations for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; lotions for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicinal tea; vaccines; food for babies; dietetic substances being fatty milk, omega-3 fish oil, amino acids, glucose, electrolytes, proteins, fats, carbohydrates, vitamins, trace elements, dietary fiber, and unsaturated fatty acids, all adapted for medical use; nutritional supplements; air purifying preparations; protein supplements for animals; medicines for veterinary purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pesticides; dressings, medical; dental lacquer
The mark consists of the stylized term "SEACROSS".
SEA CROSS

Trademark Events
Feb 14, 2023
Notice Of Registration Confirmation Emailed
Feb 14, 2023
Registered-Principal Register
Nov 29, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 29, 2022
Published For Opposition
Nov 9, 2022
Notification Of Notice Of Publication E-Mailed
Oct 26, 2022
Electronic Record Review Complete
Oct 21, 2022
On Hold - Electronic Record Review Required
Oct 17, 2022
Approved For Pub - Principal Register
Jul 26, 2022
Teas/Email Correspondence Entered
Jul 26, 2022
Correspondence Received In Law Office
Jul 26, 2022
Teas Response To Office Action Received
Feb 7, 2022
Notification Of Non-Final Action E-Mailed
Feb 7, 2022
Non-Final Action E-Mailed
Feb 7, 2022
Non-Final Action Written
Feb 2, 2022
Assigned To Examiner
Aug 18, 2021
New Application Office Supplied Data Entered
May 25, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24